25152362|t|Approaches for detecting lysosomal alkalinization and impaired degradation in fresh and cultured RPE cells: evidence for a role in retinal degenerations.
25152362|a|Lysosomes contribute to a multitude of cellular processes, and the pH of the lysosomal lumen plays a central mechanistic role in many of these functions. In addition to controlling the rate of enzymatic degradation for material delivered through autophagic or phagocytotic pathways, lysosomal pH regulates events such as lysosomal fusion with autophagosomes and the release of lysosomal calcium into the cytoplasm. Disruption of either the steady state lysosomal pH or of the regulated manipulations to lysosomal pH may be pathological. For example, chloroquine elevates the lysosomal pH of retinal pigmented epithelial (RPE) cells and triggers a retinopathy characterized by the accumulation of lipofuscin-like material in both humans and animals. Compensatory responses to restore lysosomal pH are observed; new data illustrate that chronic chloroquine treatment increases mRNA expression of the lysosomal/autophagy master transcription factor TcFEB and of the vesicular proton pump vHATPase in the RPE/choroid of mice. An elevated lysosomal pH with upregulation of TcFEB and vHATPase resembles the pathology in fibroblasts of patients with mutant presenilin 1 (PS1), suggesting a common link between age-related macular degeneration (AMD) and Alzheimer's disease. While the absolute rise in pH is often small in these disorders, elevations of only a few tenths of a pH unit can have a major impact on both lysosomal function and the accumulation of waste over decades. Accurate measurement of lysosomal pH can be complex, and imprecise measurements have clouded the field. Protocols to optimize pH measurement from fresh and cultured cells are discussed, and indirect measurements to confirm changes in lysosomal pH and degradative capacity are addressed. The ability of reacidifying treatments to restore degradative function confirms the central role of lysosomal pH in these disorders and identifies potential approaches to treat diseases of lysosomal accumulation like AMD and Alzheimer's disease. In summary, various approaches to determine lysosomal pH in fresh and cultured cells, as well as the potential to restore pH levels to an optimal range, can help identify and repair pathologies associated with lysosomal defects in RPE cells and perhaps also suggest new approaches to treat lysosomal storage diseases throughout the body. 
25152362	25	34	lysosomal	Disease	MESH:D016464
25152362	97	100	RPE	CellLine	CVCL:GQ00
25152362	131	152	retinal degenerations	Disease	MESH:D012162
25152362	231	240	lysosomal	Disease	MESH:D016464
25152362	437	446	lysosomal	Disease	MESH:D016464
25152362	475	484	lysosomal	Disease	MESH:D016464
25152362	531	540	lysosomal	Disease	MESH:D016464
25152362	541	548	calcium	Chemical	MESH:D002118
25152362	607	616	lysosomal	Disease	MESH:D016464
25152362	657	666	lysosomal	Disease	MESH:D016464
25152362	704	715	chloroquine	Chemical	MESH:D002738
25152362	729	738	lysosomal	Disease	MESH:D016464
25152362	745	762	retinal pigmented	CellLine	CVCL:GQ00
25152362	775	778	RPE	CellLine	CVCL:GQ00
25152362	801	812	retinopathy	Disease	MESH:D058437
25152362	850	860	lipofuscin	Chemical	MESH:D008062
25152362	883	889	humans	Species	9606
25152362	937	946	lysosomal	Disease	MESH:D016464
25152362	997	1008	chloroquine	Chemical	MESH:D002738
25152362	1052	1061	lysosomal	Disease	MESH:D016464
25152362	1100	1105	TcFEB	Gene	21425
25152362	1155	1158	RPE	CellLine	CVCL:GQ00
25152362	1170	1174	mice	Species	10090
25152362	1188	1197	lysosomal	Disease	MESH:D016464
25152362	1222	1227	TcFEB	Gene	21425
25152362	1283	1291	patients	Species	9606
25152362	1304	1316	presenilin 1	Gene	5663
25152362	1318	1321	PS1	Gene	5663
25152362	1357	1389	age-related macular degeneration	Disease	MESH:D008268
25152362	1391	1394	AMD	Disease	MESH:D008268
25152362	1400	1419	Alzheimer's disease	Disease	MESH:D000544
25152362	1563	1572	lysosomal	Disease	MESH:D016464
25152362	1650	1659	lysosomal	Disease	MESH:D016464
25152362	1860	1869	lysosomal	Disease	MESH:D016464
25152362	2013	2022	lysosomal	Disease	MESH:D016464
25152362	2102	2124	lysosomal accumulation	Disease	MESH:D016464
25152362	2130	2133	AMD	Disease	MESH:D008268
25152362	2138	2157	Alzheimer's disease	Disease	MESH:D000544
25152362	2203	2212	lysosomal	Disease	MESH:D016464
25152362	2369	2378	lysosomal	Disease	MESH:D016464
25152362	2390	2393	RPE	CellLine	CVCL:GQ00
25152362	2449	2475	lysosomal storage diseases	Disease	MESH:D016464
25152362	Association	MESH:D016464	5663
25152362	Positive_Correlation	MESH:D002738	MESH:D008062
25152362	Positive_Correlation	MESH:D008062	MESH:D058437
25152362	Positive_Correlation	MESH:D002738	MESH:D016464
25152362	Association	MESH:D002118	MESH:D016464
25152362	Positive_Correlation	MESH:D002738	MESH:D058437
25152362	Positive_Correlation	MESH:D002738	21425
25152362	Association	MESH:D016464	21425

